1. Home
  2. WVE

WVE

Wave Life Sciences Ltd.

Logo Wave Life Sciences Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Founded: 2012 Country:
Singapore
Singapore
Employees: 268 City: SINGAPORE
Market Cap: 643.2M IPO Year: 2015
Target Price: $12.50 AVG Volume (30 days): 896.7K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.54 EPS Growth: N/A
52 Week Low/High: $3.15 - $7.67 Next Earning Date: 05-01-2024
Revenue: $113,305,000 Revenue Growth: 3005.10%
Revenue Growth (this year): -31.92% Revenue Growth (next year): -30.83%

Share on Social Networks: